Open-label trial of a multi-strain synbiotic in cats with chronic diarrhea
Colorado State University, Veterinary Teaching Hospital, 300 West Drake Road, Fort Collins, CO 80523, USA.
Journal of feline medicine and surgery
04/2012; 14(4):240-5. DOI: 10.1177/1098612X11434386
This study was designed to test the hypothesis that in cats with chronic diarrhea the daily administration of a proprietary synbiotic (Proviable-DC) would result in an improvement in stool character, as assessed by the owner. Adult cats with chronic diarrhea were recruited for the study and screened for systemic diseases. Fecal flotation, wet mount, immunofluorescence assay (IFA) for Giardia and Cryptosporidium species, and Tritrichomonas species polymerase chain reactions (PCRs) were used to screen for intestinal parasitism. The synbiotic was administered for 21 days; otherwise, no changes were made to ongoing treatment(s) or diet. The severity of the diarrhea was assessed using a standardized fecal scoring system and the owner's subjective perception before, and after, supplementation. The mean fecal score for the 53 cats completing the study decreased from 6.0 to 4.4, representing a significantly (P <0.001) firmer stool character. Seventy-two percent of owners perceived an improvement in their cat's diarrhea following a 21-day course of synbiotic supplementation.
Available from: onlinelibrary.wiley.com
- "Probiotics use in cats with diarrhoea has shown an improvement in faecal quality (Hart et al. 2012). Studies of Lactobacillus acidophilus in dogs and cats have shown a decrease in clostridial species. "
Available from: Yasushi Minamoto
- "Chronic enteropathies, such as inflammatory bowel disease (IBD) have been associated with changes in the proportions of specific bacterial groups, especially Enterobacteriaceae and Desulfovibrio spp. in some studies (Inness et al., 2007; Janeczko et al., 2008). Conversely, some recent clinical studies suggest that the administration of specific bacterial strains or products intended to alter the intestinal microbiota (i.e., probiotics, prebiotics, or synbiotics) have the potential to improve the frequency and/or duration of diarrhea in a subset of cats with specific acute or chronic GI diseases (Bybee et al., 2011; Hart et al., 2012). While the cat is an obligate carnivore, most commercial feline diets contain moderate quantities of carbohydrates. "
[Show abstract] [Hide abstract]
ABSTRACT: The close relationship between gastrointestinal (GI) microbiota and its host has an impact on the health status of an animal that reaches beyond the GI tract. A balanced microbiome stimulates the immune system, aids in the competitive exclusion of transient pathogens and provides nutritional benefits to the host. With recent rapid advances in high-throughput sequencing technology, molecular approaches have become the routinely used tools for ecological studies of the feline microbiome, and have revealed a highly diverse and complex intestinal ecosystem in the feline GI tract. The major bacterial groups are similar to those found in other mammals, with Firmicutes, Bacteroidetes, Actinobacteria and Proteobacteria constituting more than 99% of intestinal microbiota. Several nutritional studies have demonstrated that the feline microbiota can be modulated by the amount of soluble fibers (i.e., prebiotics) and macronutrients (i.e., protein content) in the diet. Initial clinical studies have suggested the presence of a dysbiosis in feline inflammatory bowel disease (IBD). Recently, metagenomic approaches have attempted to characterize the microbial gene pool. However, more studies are needed to describe the phylogenetic and functional changes in the intestinal microbiome in disease states and in response to environmental and dietary modulations. This paper reviews recent studies cataloging the microbial phylotypes in the GI tract of cats.
[Show abstract] [Hide abstract]
ABSTRACT: Feline inflammatory bowel disease is a diagnosis of exclusion and a common cause of chronic gastrointestinal signs suhc as weight loss, variation in appetite, vomiting, diarrhea, and lethargy. Patients with intestinal small cell lymphosarcoma can present identical clinical signs, and differentiating between these two conditions can be a challenge. A companion article discusses the value of performing immunohistochemistry and polymerase chain reaction testing on intestinal biopsy samples for this purpose.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.